At a glance
ClinicalIndex Comparison RecordN/ACompleted· 101 enrolled
Drug / intervention
Albumin Humandrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Acute Burn ResUscitation Multicenter Prospective Trial (ABRUPT2)
In Brief
A clinical study evaluating Albumin Human for Burn Injury. Completed, enrolled 101 participants across 26 sites in 2 countries.
Detailed Summary
This is a prospective randomized multi-center study which will compare acute fluid resuscitation using a colloid strategy (LR + 5% Albumin) to a crystalloid strategy (LR alone), in adults with an acute burn involving at least 25% of their total body surface area.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBurn Injury
CountriesCanada, United States
CollaboratorsUnited States Department of Defense
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedApr 2020
Enrollment StartApr 2021
Primary CompletionSep 2025
TodayJul 2026
First PostedApr 22, 2020
Enrollment StartApr 22, 2021
Primary CompletionSep 29, 2025
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 6.2 years ago
Interventions
Albumin Humandrug
Addition of albumin during acute resuscitation following burn injury